Website Preloader
Our Insights

Our insights

As access experts, we keep our finger on the pulse of a fast-moving environment. We have created this space as a touchstone through which you can keep up to date with the latest expanded access activity and insights.

"
"
COVID-19 is no obstacle to Expanded Access

COVID-19 is no obstacle to Expanded Access

Marinus Pharmaceuticals initiates Global Access Program for ZTALMY® (ganaxolone) Oral Suspension CV

Marinus Pharmaceuticals initiates Global Access Program for ZTALMY® (ganaxolone) Oral Suspension CV

TFF Pharmaceuticals and Uniphar announce EAP for voriconazole inhalation powder

TFF Pharmaceuticals and Uniphar announce EAP for voriconazole inhalation powder

SIFI and Uniphar announce the opening of an Early Access Program for Akantior

SIFI and Uniphar announce the opening of an Early Access Program for Akantior

Zogenix launches Global Access Program for FINTEPLA® (Fenfluramine) Oral Solution

Zogenix launches Global Access Program for FINTEPLA® (Fenfluramine) Oral Solution